Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Active, Not Recruiting

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT06564844

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Glendale, California, United States
  • Research Site Los Angeles, California, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

NCT06898957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

MYLUNG Consortium Study Protocol 2

NCT05644808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Woodlands Medical Specialists, PA Pensacola, Florida, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT05096663

Conditions
Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations
  • Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 350 locations
View Trial Details
Active, Not Recruiting

A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer

NCT05653752

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • BRCR Global Plantation, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Next Oncology-Dallas Irving, Texas, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

NCT04380636

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0003) Mobile, Alabama, United States
  • St. Bernards Medical Center ( Site 0089) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0088) Fullerton, California, United States
  • Long Beach Memorial Medical Center ( Site 0006) Long Beach, California, United States
View all 205 locations
View Trial Details

Related conditions